Unknown

Dataset Information

0

Sexual and gender minority individuals report higher rates of abuse and more severe eating disorder symptoms than cisgender heterosexual individuals at admission to eating disorder treatment.


ABSTRACT: Eating disorders (EDs) occur at higher rates among sexual/gender minorities (SGMs). We currently know little about the risk factor profile of SGMs entering ED specialty care. OBJECTIVE:To (a) compare history of abuse-related risk in SGMs to cisgender heterosexuals (CHs) when entering treatment, (b) determine if SGMs enter and exit treatment with more severe ED symptoms than CHs, and (c) determine if SGMs have different rates of improvement in ED symptoms during treatment compared to CHs. METHOD:We analyzed data from 2,818 individuals treated at a large, US-based, ED center, 471 (17%) of whom identified as SGM. Objective 1 was tested using logistic regression and Objectives 2 and 3 used mixed-effects models. RESULTS:SGMs had higher prevalence of sexual abuse (OR = 2.10, 95% CI = 1.71, 2.58), other trauma (e.g., verbal/physical/emotional abuse; OR = 2.07, 95% CI = 1.68, 2.54), and bullying (OR = 2.13, 95% CI = 1.73, 2.62) histories. SGMs had higher global EDE-Q scores than CHs at admission (? = 0.42, SE = 0.08, p?

SUBMITTER: Mensinger JL 

PROVIDER: S-EPMC7187146 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sexual and gender minority individuals report higher rates of abuse and more severe eating disorder symptoms than cisgender heterosexual individuals at admission to eating disorder treatment.

Mensinger Janell L JL   Granche Janeway L JL   Cox Shelbi A SA   Henretty Jennifer R JR  

The International journal of eating disorders 20200313 4


Eating disorders (EDs) occur at higher rates among sexual/gender minorities (SGMs). We currently know little about the risk factor profile of SGMs entering ED specialty care.<h4>Objective</h4>To (a) compare history of abuse-related risk in SGMs to cisgender heterosexuals (CHs) when entering treatment, (b) determine if SGMs enter and exit treatment with more severe ED symptoms than CHs, and (c) determine if SGMs have different rates of improvement in ED symptoms during treatment compared to CHs.<  ...[more]

Similar Datasets

| S-EPMC10441544 | biostudies-literature
| S-EPMC9996424 | biostudies-literature
| S-EPMC9359347 | biostudies-literature
| S-EPMC7275693 | biostudies-literature
| S-EPMC10486222 | biostudies-literature
| S-EPMC7262419 | biostudies-literature
| S-EPMC8186088 | biostudies-literature
| S-EPMC10535091 | biostudies-literature
| S-EPMC7203670 | biostudies-literature
| S-EPMC6430403 | biostudies-literature